Novo Holdings A/S Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$939.1B
Holdings
22
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INGNINOGEN INC | 3,549,320 | $275.3B | 29.31% | |
| 2 | ANABANAPTYSBIO INC | 3,033,504 | $84.2B | 8.96% | |
| 3 | RETAEURREATA PHARMACEUTICALS INC | 3,367,763 | $76.3B | 8.12% | |
| 4 | IRTCIRHYTHM TECHNOLOGIES INC | 2,024,448 | $76.1B | 8.11% | |
| 5 | CRVSCORVUS PHARMACEUTICALS INC | 3,224,046 | $67.0B | 7.13% | |
| 6 | —RA PHARMACEUTICALS INC | 2,031,562 | $43.3B | 4.61% | |
| 7 | XLRNACCELERON PHARMA INC | 1,553,937 | $41.1B | 4.38% | |
| 8 | —FLEXION THERAPEUTICS INC | 1,397,718 | $37.6B | 4.01% | |
| 9 | MRUSMERUS N V | 1,410,417 | $34.4B | 3.66% | |
| 10 | —SPECTRANETICS CORP | 1,179,122 | $34.3B | 3.66% | |
| 11 | —OBSEVA SA | 3,044,093 | $31.7B | 3.37% | |
| 12 | —NABRIVA THERAPEUTICS AG | 2,326,544 | $27.9B | 2.97% | |
| 13 | —DERMIRA INC | 748,240 | $25.5B | 2.72% | |
| 14 | KALVKALVISTA PHARMACEUTICALS INC | 2,901,927 | $22.7B | 2.41% | |
| 15 | —APOLLO ENDOSURGERY INC | 1,456,972 | $18.2B | 1.94% | |
| 16 | AKBAAKEBIA THERAPEUTICS INC | 1,272,247 | $11.7B | 1.25% | |
| 17 | —INVUITY INC | 1,318,448 | $10.5B | 1.12% | |
| 18 | —HTG MOLECULAR DIAGNOSTICS INC | 1,280,185 | $8.9B | 0.94% | |
| 19 | —WRIGHT MED GROUP N V | 4,622,032 | $7.1B | 0.75% | |
| 20 | CRSPCRISPR THERAPEUTICS AG | 223,317 | $4.9B | 0.52% | |
| 21 | XENEXENON PHARMACEUTICALS INC | 127,563 | $510.0M | 0.05% | |
| 22 | OPKOPKO HEALTH INC | 259 | $2.0M | 0.00% |